Search Results - "Rodnitzky, R L"

Visual dysfunction in Parkinson disease without dementia by UC, E. Y, RIZZO, M, ANDERSON, S. W, QIAN, S, RODNITZKY, R. L, DAWSON, J. D

“…To determine the profiles of visual dysfunction and their relationship to motor and cognitive dysfunction and to disability in mild to moderate Parkinson…”
Get full text

Driving with distraction in parkinson disease by UC, E. Y, RIZZO, M, ANDERSON, S. W, SPARKS, J. D, RODNITZKY, R. L, DAWSON, J. D

“…To assess the effects of auditory-verbal distraction on driving performance in Parkinson disease (PD). We tested licensed, currently active drivers with…”
Get full text

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia by BRASHEAR, A, LEW, M. F, WALLACE, J. D, WILLMER-HULME, A, KOLLER, M, DYKSTRA, D. D, COMELLA, C. L, FACTOR, S. A, RODNITZKY, R. L, TROSCH, R, SINGER, C, BRIN, M. F, MURRAY, J. J

“…To determine the safety and efficacy of botulinum toxin type B (BoNT/B) in patients with cervical dystonia (CD). BoNT/B is a form of chemodenervation therapy…”
Get full text

Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia by LEW, M. F, ADORNATO, B. T, SWENSON, M. R, TARSY, D, MURRAY, J. J, KOLLER, M, WALLACE, J. D, DUANE, D. D, DYKSTRA, D. D, FACTOR, S. A, MASSEY, J. M, BRIN, M. F, JANKOVIC, J, RODNITZKY, R. L, SINGER, C

“…We enrolled and treated 122 patients with idiopathic cervical dystonia in a double-blind, placebo-controlled safety and efficacy study of botulinum toxin type…”
Get full text

The health burdens of Parkinson's disease by Chrischilles, Elizabeth A., Rubenstein, Linda M., Voelker, Margaret D., Wallace, Robert B., Rodnitzky, Robert L.

“…Parkinson's disease (PD) is likely to have a substantial impact on an individual's health‐related quality of life (HRQL), health‐related resource use, and…”
Get full text

Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease by HUTTON, J. T, KOLLER, W. C, MUENTER, M. D, ADLER, C. H, MORRIS, J. L, AHLSKOG, J. E, PAHWA, R, HURTIG, H. I, STERN, M. B, HINER, B. C, LIEBERMAN, A, RODNITZKY, R. L, WATERS, C. H

“…Cabergoline is a dopaminergic agonist relatively specific for the D2 receptor and much longer-acting than other dopamine agonists. We conducted a randomized,…”
Get full text

Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration by Wszolek, Z K, Pfeiffer, R F, Bhatt, M H, Schelper, R L, Cordes, M, Snow, B J, Rodnitzky, R L, Wolters, E C, Arwert, F, Calne, D B

“…We describe a family with nearly 300 members over 8 generations with 32 affected individuals who have an autosomal dominant neurodegenerative disease…”
Get more information

Can calcium antagonists provide a neuroprotective effect in Parkinson's disease? by RODNITZKY, R. L

“…Although major strides forward have been made in the symptomatic treatment of Parkinson's disease (PD), effective neuroprotective therapies have not yet been…”
Get full text

Localization of the Gene for Rapidly Progressive Autosomal Dominant Parkinsonism and Dementia with Pallido-Ponto-Nigral Degeneration to Chromosome 17q21 by Wijker, Mario, Wszolek, Zbigniew K., Wolters, Eric C. H., Rooimans, Martin A., Pals, Gerard, Pfeiffer, Ronald F., Lynch, Timothy, Rodnitzky, R. L., Wilhelmsen, Kirk C., Arwert, Fré

“…Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration (PPND) is a neurodegenerative disorder which begins…”
Get full text

The importance of formal serum iron studies in the assessment of restless legs syndrome by AUL, E. A, DAVIS, B. J, RODNITZKY, R. L

Get full text

Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism by WSZOLEK, Z. K, GWINN-HARDY, K, WSZOLEK, E. K, MUENTER, M. D, PFEIFFER, R. F, RODNITZKY, R. L, UITTI, R. J, MCCOMB, R. D, GASSER, T, DICKSON, D. W

“…We present genealogical and longitudinal clinical observations and autopsy findings of a previously reported kindred, Family C (German-American), with…”
Get full text

The Usefulness of the Functional Status Questionnaire and Medical Outcomes Study Short Form in Parkinson's Disease Research by L. M. Rubenstein, M. D. Voelker, Chrischilles, E. A., D. C. Glenn, Wallace, R. B., R. L. Rodnitzky

“…Parkinson's disease (PD) has no cure and is a progressive neurological disorder with treatment aimed at the maintenance of function and limitation of the…”
Get full text

The use of sinemet CR in the management of mild to moderate Parkinson's disease by RODNITZKY, R. L

“…The pharmacokinetic advantage of controlled-release carbidopa-levodopa (Sinemet CR) is its slow dissolution and gradual absorption, resulting in more sustained…”
Get full text

Stroke and its modification in Parkinson's disease by STRUCK, L. K, RODNITZKY, R. L, DOBSON, J. K

“…Previous studies have not agreed on the incidence of ischemic stroke in persons with Parkinson's disease. There are epidemiologic and neurochemical facets of…”
Get full text

Visual dysfunction in Parkinson's disease by Rodnitzky, R L

“…Several abnormalities of visual function have been demonstrated in Parkinson's disease (PD) by both electrophysiologic and psychophysical testing. Prolonged…”
Get more information

Circadian fluctuations of contrast sensitivity in Parkinson's disease by STRUCK, L. K, RODNITZKY, R. L, DOBSON, J. K

“…Spontaneous circadian fluctuations of motor symptoms in Parkinson's disease (PD) often occur, with dysfunction typically less severe in the early morning than…”
Get full text

Botulinum toxin enhancement of postoperative immobilization in patients with cervical dystonia : technical note by TRAYNELIS, V. C, RYKEN, T, RODNITZKY, R. L, MENEZES, A. H

“…Postoperative immobilization in patients with cervical dystonia requiring fusion presents a unique management problem. Two patients with severe degenerative…”
Get full text

Ranitidine-induced cranial dystonia by Davis, B J, Aul, E A, Granner, M A, Rodnitzky, R L

“…We report a case of cranial dystonia related to the administration of ranitidine. The symptoms started shortly after institution of treatment, resolved after…”
Get more information

Relation between size of compound sensory or muscle action potentials, and length of nerve segment by KIMURA, J, MACHIDA, M, ISHIDA, T, YAMADA, T, RODNITZKY, R. L, KUDO, Y, SUZUKI, S

“…In 24 median nerves from 12 healthy subjects, antidromic digital sensory potentials progressively diminished in size, averaging 40.4, 37.0, 30.7, and 23.9…”
Get full text

Neurologic complications of drugs. Tardive dyskinesias, neuroleptic malignant syndrome, and cocaine-related syndromes by Rodnitzky, R L, Keyser, D L

“…Drugs, either self-administered or prescribed by physicians, can result in substantial neurologic disability in psychiatric patients. It is clear that the use…”
Get more information